[go: up one dir, main page]

CA2525778A1 - Epitopes de lymphocytes t utiles en tant que vaccin contre le virus du syndrome respiratoire aigu severe (sras) et en tant qu'outils diagnostiques et procedes d'identification associes - Google Patents

Epitopes de lymphocytes t utiles en tant que vaccin contre le virus du syndrome respiratoire aigu severe (sras) et en tant qu'outils diagnostiques et procedes d'identification associes Download PDF

Info

Publication number
CA2525778A1
CA2525778A1 CA002525778A CA2525778A CA2525778A1 CA 2525778 A1 CA2525778 A1 CA 2525778A1 CA 002525778 A CA002525778 A CA 002525778A CA 2525778 A CA2525778 A CA 2525778A CA 2525778 A1 CA2525778 A1 CA 2525778A1
Authority
CA
Canada
Prior art keywords
seq
sars
leu
prt
val
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
CA002525778A
Other languages
English (en)
Inventor
Morten Nielsen
Ole Lund
Claus Lundegaard
Peder Worning
Soren Buus
Soren Brunak
Sune Justesen
Christina Sylvester-Hvid
Gustav A. Roder
Kasper Lamberth
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Siga Technologies Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Siga Technologies Inc filed Critical Siga Technologies Inc
Publication of CA2525778A1 publication Critical patent/CA2525778A1/fr
Abandoned legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K39/12Viral antigens
    • A61K39/215Coronaviridae, e.g. avian infectious bronchitis virus
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K39/12Viral antigens
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K2039/51Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/53DNA (RNA) vaccination
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2770/00MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
    • C12N2770/00011Details
    • C12N2770/20011Coronaviridae
    • C12N2770/20022New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2770/00MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
    • C12N2770/00011Details
    • C12N2770/20011Coronaviridae
    • C12N2770/20034Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/005Assays involving biological materials from specific organisms or of a specific nature from viruses
    • G01N2333/08RNA viruses
    • G01N2333/165Coronaviridae, e.g. avian infectious bronchitis virus

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Virology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Mycology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Microbiology (AREA)
  • Immunology (AREA)
  • Veterinary Medicine (AREA)
  • Organic Chemistry (AREA)
  • Pulmonology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Communicable Diseases (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
CA002525778A 2003-05-14 2004-05-14 Epitopes de lymphocytes t utiles en tant que vaccin contre le virus du syndrome respiratoire aigu severe (sras) et en tant qu'outils diagnostiques et procedes d'identification associes Abandoned CA2525778A1 (fr)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
DKPA200300725 2003-05-14
DKPA200300725 2003-05-14
PCT/US2004/015026 WO2004110349A2 (fr) 2003-05-14 2004-05-14 Epitopes de lymphocytes t utiles en tant que vaccin contre le virus du syndrome respiratoire aigu severe (sras) et en tant qu'outils diagnostiques et procedes d'identification associes

Publications (1)

Publication Number Publication Date
CA2525778A1 true CA2525778A1 (fr) 2004-12-23

Family

ID=33547529

Family Applications (1)

Application Number Title Priority Date Filing Date
CA002525778A Abandoned CA2525778A1 (fr) 2003-05-14 2004-05-14 Epitopes de lymphocytes t utiles en tant que vaccin contre le virus du syndrome respiratoire aigu severe (sras) et en tant qu'outils diagnostiques et procedes d'identification associes

Country Status (3)

Country Link
CA (1) CA2525778A1 (fr)
IL (1) IL171924A0 (fr)
WO (1) WO2004110349A2 (fr)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2009055005A2 (fr) * 2007-10-23 2009-04-30 The Regents Of The University Of Colorado Inhibiteurs compétitifs de l'expression de chaînes invariantes et/ou d'une liaison d'un clip ectopique
JP5686370B2 (ja) * 2008-11-28 2015-03-18 日油株式会社 Sarsコロナウイルスの細胞傷害性t細胞エピトープペプチド及びその用途
WO2018102317A1 (fr) * 2016-11-29 2018-06-07 The Regents Of The University Of California Modulation de p53 pour le traitement du cancer
EP3892297A1 (fr) * 2020-04-09 2021-10-13 Eberhard Karls Universität Tübingen Medizinische Fakultät Peptides et combinaisons de peptides à utiliser en immunothérapie contre une infection par le sars-cov-2 (covid-19)
CN111440229B (zh) * 2020-04-13 2021-08-03 中国人民解放军军事科学院军事医学研究院 新型冠状病毒t细胞表位及其应用
WO2021216615A1 (fr) * 2020-04-20 2021-10-28 The General Hospital Corporation Composition immunogène de coronavirus à épitopes ayant un score de réseau élevé
EP4138895A2 (fr) * 2020-04-20 2023-03-01 NEC OncoImmunity AS Vaccins contre le sars-cov-2
WO2021228853A1 (fr) * 2020-05-11 2021-11-18 Ose Immunotherapeutics Vaccin contre le virus sras-cov
WO2021256795A1 (fr) * 2020-06-15 2021-12-23 한국과학기술원 Épitope du nouveau coronavirus et son utilisation
EP4168028A4 (fr) * 2020-06-17 2024-10-23 Tscan Therapeutics, Inc. Peptides immunodominants de sars-cov-2 et leurs utilisations
WO2022026921A1 (fr) * 2020-07-30 2022-02-03 Repertoire Immune Medicines, Inc. Identification et utilisation d'épitopes de lymphocytes t dans la conception d'approches diagnostiques et thérapeutiques associées à la covid-19
WO2022067062A1 (fr) * 2020-09-24 2022-03-31 Epivax, Inc. Développement rapide d'un vaccin prophylactique à large spectre pour le sars-cov-2 à l'aide d'un système d'administration d'antigène à médiation par phage
JP2023550094A (ja) * 2020-11-12 2023-11-30 ティースキャン セラピューティクス インコーポレイテッド Sars-cov-2免疫優性ペプチドの構築物及びその使用
CN112876542B (zh) * 2021-02-08 2021-10-29 暨南大学 一种新型冠状病毒t细胞的抗原表位肽及其应用
EP4294833A2 (fr) * 2021-02-22 2023-12-27 Cotropia, Joseph Antigènes et épitopes de virus corona et protéines se liant à ceux-ci
WO2022215079A1 (fr) * 2021-04-08 2022-10-13 Ramot At Tel-Aviv University Ltd. Nanovaccins destinés au traitement de maladies virales
WO2022268916A2 (fr) 2021-06-23 2022-12-29 Ose Immunotherapeutics Vaccin peptidique pan-coronavirus
CN113666989B (zh) * 2021-08-12 2023-08-29 中国科学技术大学 新型冠状病毒cd8+ t细胞表位肽及其用途

Also Published As

Publication number Publication date
WO2004110349A2 (fr) 2004-12-23
IL171924A0 (en) 2006-04-10
WO2004110349A3 (fr) 2006-03-23

Similar Documents

Publication Publication Date Title
CA2525778A1 (fr) Epitopes de lymphocytes t utiles en tant que vaccin contre le virus du syndrome respiratoire aigu severe (sras) et en tant qu'outils diagnostiques et procedes d'identification associes
Raoufi et al. Epitope prediction by novel immunoinformatics approach: a state-of-the-art review
US11183272B2 (en) Method and systems for prediction of HLA class II-specific epitopes and characterization of CD4+ T cells
Sette et al. The development of multi-epitope vaccines: epitope identification, vaccine design and clinical evaluation
Doolan et al. Identification of Plasmodium falciparum antigens by antigenic analysis of genomic and proteomic data
Paul et al. HLA class I alleles are associated with peptide-binding repertoires of different size, affinity, and immunogenicity
De Groot et al. Immuno‐informatics: Mining genomes for vaccine components
Sidney et al. HLA class I supertypes: a revised and updated classification
Yu et al. Methods for prediction of peptide binding to MHC molecules: a comparative study
Wang et al. A systematic assessment of MHC class II peptide binding predictions and evaluation of a consensus approach
CN112771214B (zh) 用于选择新表位的方法
Sun et al. Advances in in-silico B-cell epitope prediction
Rivino et al. Defining CD8+ T cell determinants during human viral infection in populations of Asian ethnicity
Nussbaum et al. Using the World Wide Web for predicting CTL epitopes
Bresciani et al. T‐cell recognition is shaped by epitope sequence conservation in the host proteome and microbiome
Dikhit et al. The potential HLA Class I-restricted epitopes derived from LeIF and TSA of Leishmania donovani evoke anti-leishmania CD8+ T lymphocyte response
Florea et al. Epitope prediction algorithms for peptide-based vaccine design
Wei et al. Advances of computational methods enhance the development of multi-epitope vaccines
Hamed et al. State of the art in epitope mapping and opportunities in COVID-19
Awad et al. Immunoinformatics approach of epitope prediction for SARS-CoV-2
WO2005042698A2 (fr) Epitopes de lymphocyte t s'utilisant dans le vaccin du virus de l'hepatite c et comme outils diagnostiques, et methodes permettant de les identifier
Patwary et al. In silico structure analysis and epitope prediction of E3 CR1-beta protein of Human Adenovirus E for vaccine design
WO2023225207A2 (fr) Procédé et systèmes de prédiction d'épitopes spécifiques des hla de classe ii et caractérisation de lymphocytes t cd4+
Charo et al. The identification of a common pathogen‐specific HLA class I A* 0201‐restricted cytotoxic T cell epitope encoded within the heat shock protein 65
Brusic et al. Computational binding assays of antigenic peptides

Legal Events

Date Code Title Description
FZDE Discontinued